Yes, DNA profiling can be used to predict an individual's risk of developing certain types of cancer. Genetic tests can identify inherited mutations in genes such as TP53, MLH1, and MSH2, which are associated with hereditary cancer syndromes like Lynch syndrome. Early identification of these genetic predispositions allows for proactive monitoring and preventive measures, potentially reducing the risk of cancer development.